(ANN ARBOR, Mich. – September 4, 2019) Swift Biosciences announced the launch of its Swift RNA Library Kits today. Leveraging the company’s innovative and patented Adaptase® technology, the Swift RNA Library Kits allow direct conversion of first-strand complementary DNA (cDNA), reverse transcribed from RNA, into high-quality libraries for Illumina® sequencing. Swift is entering the RNA-Seq market with two kits, the Swift RNA Library Kit which supports a broad input range and demonstrates superior data […]
Saphetor SA and Swift Biosciences announce partnership to standardize and accelerate data interpretation for targeted NGS panelsMary Lukens2019-07-22T15:45:46+00:00
Lausanne, June 12th, 2019
Saphetor SA, a Swiss precision medicine company and the creator of VarSome, a suite of bioinformatics solutions, announced today a partnership with Swift Biosciences Inc., a Michigan company based in Ann Arbor, USA, offering a set of differentiated next-generation sequencing (NGS) products and technologies for genomics, translational, and clinical research applications.
Saphetor’s VarSome Clinical, a clinically-certified cloud-based platform empowering fast and accurate variant discovery, annotation, and interpretation of NGS data is now […]
Swift Biosciences Launches Swift Hybridization Capture Kits for Targeted Sequencing of Human Exome, Pan-Cancer and Inherited DiseasesMary Lukens2019-06-12T16:50:40+00:00
(ANN ARBOR, Mich. – March 26, 2019) Swift Biosciences today announced the launch of its Swift Hybridization Capture Kits, enabling enrichment and sequencing of the human exome or subsets of disease-related genes involved in cancer and inherited diseases. Swift Hybridization Capture Kits save sequencing costs by targeting only genes of interest using a 4-hour capture, while delivering the breadth and depth of coverage required for comprehensive yet sensitive genomic profiling.
This product includes gene-specific capture […]
The NEW Swift 2S Turbo DNA Library Kits are a fast, efficient and cost-effective library prep solution. Leveraging a robust enzymatic fragmentation prep and flexible indexing, you can prepare high-quality whole genome and exome libraries using a broad range of input amounts and sample types.
Swift Biosciences Launches Swift Amplicon 16S+ITS Panel, Answering Long-Awaited Need for Comprehensive, Rapid Coverage of Metagenomic Sequences by NGSJessy Robison2019-02-25T17:04:56+00:00
(ANN ARBOR, Mich. – January 16, 2019) Swift Biosciences today announced the launch of its Swift Amplicon 16S+ITS Panel, facilitating routine NGS analysis of complex microbial samples (e.g. bacteria, archaea, fungi) using a single, multiplexed primer pool targeting the 16S rRNA gene (all variable regions, V1-V9) and ITS1 and ITS2 for fungi. With a comprehensive yet targeted library approach in a single-tube assay, the panel enriches the sequences used for identifying the structure of […]
Ann Arbor, Michigan (January 7, 2019) – Swift Biosciences, Inc. a manufacturer of precision next-generation sequencing (NGS) solutions, announces it has received International Organization Standardization (ISO) 13485:2016 certification for design, development, production, and distribution of molecular biology and related reagents in both standard and custom formats has been assessed and approved by National Quality assurance, USA with zero non-conformances, the best result possible.
The ISO 13485:2016 certificate was issued to Swift Biosciences by the National […]
Swift Biosciences Launches Normalase™, Radically Streamlining and Improving NGS Library NormalizationJessy Robison2018-11-28T09:00:29+00:00
(ANN ARBOR, Mich. – November 28, 2018) Swift Biosciences today announced the availability of its eagerly anticipated Normalase™ Kit, a revolutionary enzymatic library normalization product that streamlines the cumbersome steps following next-generation sequencing (NGS) library preparation. Compared to conventional normalization, Swift Normalase saves cost on sequencing by reducing read depth variation within a pool down to a coefficient of variation <10%.
Normalase provides an efficient, robust, scalable and cost-effective means to significantly reduce […]
Swift Biosciences Launches Swift Amplicon HS Panels, Enabling Confident Targeted Detection of Low Frequency Variants from Liquid Biopsy SequencingJessy Robison2018-08-28T13:13:04+00:00
(ANN ARBOR, Mich. – Aug. 28, 2018 ) Swift Biosciences today announced early access availability of its Swift Amplicon HS Panels, a new, high-sensitivity targeted amplicon library preparation kit for next-generation sequencing (NGS) of liquid biopsy samples, including cell-free DNA (cfDNA). This addition to Swift’s targeted NGS portfolio facilitates the detection and validation of mutations occurring at 0.25-3.0% frequency among a background or host sample. This capability is especially useful for oncology and newborn […]
Swift Biosciences Launches Swift 2S Turbo Library Kit, Accelerating Whole Genome, Exome and Large Gene Studies with One Universal ApproachJessy Robison2018-07-18T19:18:43+00:00
(ANN ARBOR, Mich. – July 18, 2018) Swift Biosciences, a leading provider of innovative library prep solutions for next-generation sequencing (NGS), today announced early access to its Swift 2S Turbo Library Kit. These new kits offer a fast, robust enzymatic fragmentation prep and flexible adapter options to produce high-quality libraries for production-scale sequencing.
With an automation friendly workflow, the Swift 2S Turbo Library Kit™ is a universal library prep kit, compatible with variety of applications […]
Swift Biosciences and Genomenon Announce Partnership to Accelerate Biomarker Selection for Targeted NGS PanelsJessy Robison2019-03-18T20:10:41+00:00
Two Ann Arbor biotech companies provide translational researchers a faster, more comprehensive way to design Accel-Amplicon panels for variant discovery and screening studies
(ANN ARBOR, Michigan – May 23, 2018) – Swift Biosciences—the NGS Library Prep company—and Genomenon—the leading genomic literature search engine company— announced today a new partnership to revolutionize the design of targeted gene sequencing panels for precision medicine initiatives.
Genomenon and Swift will co-market solutions in an integrated offering to make it easier […]
Results-driven, customer-focused leader to drive continued expansion in personalized medicine, disease research markets
(ANN ARBOR, Mich. – May 22, 2018) Swift Biosciences, a leading provider of innovative library prep solutions for genomic sequencing, today named industry veteran Nathan Wood as its new CEO. The hire is the latest in a recent series of strategic moves by Swift to solidify its position serving the personalized medicine, drug […]
New targeted sequencing workflow combines pre-validated content with easy customization and new analysis tools to accelerate variant discovery and screening
(ANN ARBOR, Mich. – April 18, 2018) Swift Biosciences today announced the commercial release of its Accel-Amplicon™ Plus Cancer Panels, a suite of nine tumor-specific and focused gene panels to facilitate targeted cancer sequencing. The Accel-Amplicon technology enables simultaneous detection of single nucleotide variants, copy number variants […]
Swift Biosciences Launches Unique Dual Indexing Kits to improve Multiplexed Next Generation SequencingJessy Robison2018-04-06T13:30:05+00:00
New Accel-NGS Unique Dual Indexing Kits minimize read misassignments for higher quality results
(ANN ARBOR, Mich. – April 6, 2018) Swift Biosciences today announced the launch of its Accel-NGS® Unique Dual Indexing Kits, which deliver the power and value of high-throughput multiplexed sequencing while improving the accuracy of low frequency variant calling, such as somatic mutations, in samples such as FFPE and cfDNA.
Multiplexed sequencing is a commonly used technique among clinical research, drug development and […]
Swift Launches Accel-Amplicon™ Custom NGS Panels, Accelerating Variant Discovery in Challenging Biological SamplesJessy Robison2019-03-25T20:47:22+00:00
Genialis/Swift partnership delivers a complete targeted sequencing solution with intuitive analysis software
(ANN ARBOR, Mich. – Oct. 12, 2017) Swift Biosciences, a leading provider of innovative library prep solutions for next-generation sequencing (NGS), today announced the launch of its Accel-Amplicon™ Custom NGS Panels. These new panels offer a targeted DNA sequencing product that enables clinical researchers to rapidly design highly focused panels to discover, validate and screen disease genes and their variants.
With the quickest workflow, […]
Michigan company doubles size of Ann Arbor-based operations and expands to San Francisco with new commercial office space
(ANN ARBOR, Mich. and SOUTH SAN FRANCISCO – October 5, 2017) Swift Biosciences, a leading provider of innovative library-prep solutions for genomic sequencing, today announced the move and expansion of their headquarters in Ann Arbor, Michigan, and the opening of an office in the San Francisco Bay Area. These new facilities in two fast-growing marketplaces will enable Swift […]
Study published in Science magazine demonstrates how epigenetic markers can identify cell subtypes and regulatory elements that drive cellular diversity
(ANN ARBOR, Mich. – August 10, 2017) Swift Biosciences, a leading provider of innovative library prep solutions for next-generation sequencing (NGS), today announced the launch of a new single-cell methylation sequencing method based on its Accel-NGS® Adaptase™ technology, an efficient and robust NGS-prep solution for whole-genome bisulfite sequencing at single-cell resolution. This new method enables […]
Swift Biosciences Announces New Industry-Leading Indexed Adapters for Sequencing Larger Numbers of Samples in a Single RunJessy Robison2019-03-25T20:51:33+00:00
Revolutionary technology will accelerate utility of gene mapping, biomarker discovery, tumor profiling, and liquid biopsy analysis. Swift Biosciences, a leading provider of innovative library prep solutions for genomic sequencing, today announced the launch of Accel-NGS® 2S Indexed Adapters, a new portfolio of indices that significantly improves multiplexed next-generation
Company completes Series D funding and adds two new directors to board. Swift Biosciences, a leading provider of innovative library prep solutions for genomic sequencing, today announced the completion of a Series D funding raise of $12.2 million. The company also announced the addition of two new directors to its board, positioning the company for accelerated growth. The Series D round was led by Arboretum Ventures